Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2501)	8/28/2009 3:07:29 PM
From: Jibacoa	Read Replies (1) of 3722

In spite of its large LTD, PARD has a good institutional following.<g> The former NeoRX, has a PIII on I.V. picoplatin in SCLCs,a PII on metastatic colorectal CAs, and another PII on hormone refractory prostatic Cas. It also has a trial of oral picoplatin in solid tumors. The stock continues on the near term UT that started on Apr28 from the $2 level. bigcharts.marketwatch.com As previously mentioned, the insiders which hold a good % of the stock, had been buying prior to the start of the recent UT.It seems thay had some good inside information. <g> The stock has had an impressive up-move so far, including today's good % gain.<g> bigcharts.marketwatch.com And with its large LTD and fast burning rate, it will be important to see how it will handle the resistance at the $10 level. Perhaps the insiders could give again a good clue.(So far they are still on a buying mood.<g>) finance.yahoo.com Although the resistace from the Jun2007 of $8.95 to Feb2006 H at $9.90 is important, the one from that level to the Dec2004 H of $16.80 looks like a more difficult climb.<g> bigcharts.marketwatch.com However, if PARD can come out with some good news on its Ps on picoplastin, it has plenty of previous taxable losses it can use and also has plenty of room to run. Although the climb to test previous Hs at the $50, $150 and above still look like a rather steep climb.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next